IGC Pharma Inc (IGC)

Jun 17, 2025

IGC Pharma Highlights Alzheimer’s Research Progress - TipRanks

Jun 17, 2025

Jun 02, 2025

BARDA’s $375M to Shionogi for COVID-19 tops early list of 2025 grants - BioWorld MedTech

Jun 02, 2025

May 30, 2025

Plus Therapeutics (PSTV) Reports Q1 Loss, Misses Revenue Estimates - sharewise

May 30, 2025

May 22, 2025

IGC Pharma Launches Clinical Trial Site in Puerto Rico | IGC Sto - GuruFocus

May 22, 2025

May 22, 2025

IGC Pharma Launches Clinical Trial Site in Puerto Rico | IGC Stock News - GuruFocus

May 22, 2025

May 22, 2025

IGC Pharma's Puerto Rico CALMA Trial Site Offers Strategic Opportunity in High-Prevalence Alzheimer's Market | IGC Stock News - GuruFocus

May 22, 2025

May 22, 2025

IGC Pharma's Puerto Rico CALMA Trial Site Offers Strategic Opportunity in High-Prevalence Alzheimer's Market - ACCESS Newswire

May 22, 2025

May 22, 2025

IGC Pharma Targets Puerto Rico's 12.5% Alzheimer's Rate in Strategic Trial Expansion - Stock Titan

May 22, 2025

May 22, 2025

IGC Pharma's Puerto Rico CALMA Trial Site Offers Strategic Oppor - GuruFocus

May 22, 2025

May 13, 2025

IGC Pharma Presents Genetic Toxicology Safety Data on API in IGC - GuruFocus

May 13, 2025

May 12, 2025

IGCPharma (IGC) Confirms Genetic Safety of Alzheimer's Drug Ingr - GuruFocus

May 12, 2025

May 12, 2025

IGC Pharma Presents Genetic Toxicology Safety Data on API in IGC-AD1, at the 2025 Genetic Toxicology Association Meeting - ACCESS Newswire

May 12, 2025

May 04, 2025

IGC Pharma Reports Second Quarter Fiscal 2025 Results, Showcasing Progress in Its Alzheimer’s Pipeline - Seeking Alpha

May 04, 2025

Apr 26, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 26, 2025

Apr 26, 2025

IGC Pharma Announces Equity Analyst Update by Alliance Global Partners (AGP) about the "Progressing Alzheimer-targeting efforts with notable Phase 2 CALMA interim results" - ACCESS Newswire

Apr 26, 2025

Apr 26, 2025

IGC Pharma Names IGC-AD1 Phase 2 Clinical Trial for Alzheimer's Agitation "CALMA" and Expands Recruitment Strategy - ACCESS Newswire

Apr 26, 2025

Apr 25, 2025

Is IGC Pharma Inc (IGC) a good investment opportunity? - uspostnews.com

Apr 25, 2025

Apr 25, 2025

IGC Pharma Announces Participation in BioPartnering at JPM Alongside the J.P. Morgan 43rd Annual Healthcare Conference 2025 - ACCESS Newswire

Apr 25, 2025

Apr 24, 2025

IGC Pharma Welcomes Strategic Investment from Advisors - PharmiWeb.com

Apr 24, 2025

Apr 24, 2025

IGC Pharma (IGC) Secures $475K Investment to Advance Alzheimer's Trial | IGC Stock News - GuruFocus

Apr 24, 2025

Apr 24, 2025

IGC Pharma Welcomes Strategic Investment from Advisors | IGC Sto - GuruFocus

Apr 24, 2025

Apr 24, 2025

IGC Pharma Welcomes Strategic Investment From Advisors - Barchart.com

Apr 24, 2025

Apr 23, 2025

The 7 Best Stocks Under 50 Cents To Buy For June 2025! - The Stock Dork

Apr 23, 2025

Apr 21, 2025

IGC Pharma Welcomes Industry Leaders to Advisory Board, Supporti - GuruFocus

Apr 21, 2025

Apr 21, 2025

IGC Pharma Welcomes Industry Leaders to Advisory Board, Supporting Alzheimer's Innovation and AI-Driven Programs | IGC Stock News - GuruFocus

Apr 21, 2025

Apr 21, 2025

Former MassBio CEO Joins IGC Pharma's Advisory Board to Advance AI-Powered Alzheimer's Programs - Stock Titan

Apr 21, 2025

Apr 18, 2025

India Globalization Capital : IGC Announces Results of its 2020 Annual Stockholders Meeting - marketscreener.com

Apr 18, 2025

Apr 16, 2025

IGC Pharma, Inc. (IGC) Reports Q3 Loss, Tops Revenue Estimates - MSN

Apr 16, 2025

Apr 09, 2025

IGC Pharma expands CALMA trial with addition of Butler Hospital Program - Yahoo Finance

Apr 09, 2025

Apr 08, 2025

IGC Pharma Expands Phase 2 Alzheimer's Trial Site - marketscreener.com

Apr 08, 2025

Apr 08, 2025

IGC Pharma Expands CALMA Alzheimer's Phase 2 Trial with Prestigious Research Site at Butler Hospital's Memory and Aging Program - Newswire.com

Apr 08, 2025

Apr 02, 2025

IGC Pharma Announces CALMA Phase 2 Trial Expansion with the Addition of Miami Jewish Health - BioSpace

Apr 02, 2025

Apr 01, 2025

IGC Pharma Announces CALMA Phase 2 Trial Expansion with the Addi - GuruFocus

Apr 01, 2025

Apr 01, 2025

IGC Pharma announces CALMA Phase 2 trial expansion with Miami Jewish Health - TipRanks

Apr 01, 2025

Apr 01, 2025

IGC Pharma expands CALMA clinical trial - TipRanks

Apr 01, 2025

Apr 01, 2025

IGC Pharma Accelerates Alzheimer's Breakthrough: Key Research Center Joins Phase 2 Trial - Stock Titan

Apr 01, 2025

Mar 27, 2025

IGC Pharma posts promising interim data for Alzheimer’s therapy - MSN

Mar 27, 2025

Mar 27, 2025

IGC Pharma's Phase 2 Clinical Trial Interim Data Demonstrates Significant Reduction in Sleep Disturbances - BioSpace

Mar 27, 2025

Mar 26, 2025

Breakthrough: New Alzheimer's Drug Cuts Sleep Disturbances by 78% in Phase 2 Trial - Stock Titan

Mar 26, 2025

Mar 21, 2025

IGC adds new clinical site in Canada for Alzheimer’s agitation therapy trial - Clinical Trials Arena

Mar 21, 2025

Mar 20, 2025

IGC Pharma Announces CALMA Phase 2 Trial Expansion with the Addition of Canadian Hamilton Health Sciences - BioSpace

Mar 20, 2025

Mar 20, 2025

IGC Pharma Adds Canadian Site to Phase 2 Trial of Investigational Alzheimer's Dementia Therapy - MarketScreener

Mar 20, 2025

Mar 17, 2025

IGC Pharma Expands CALMA Trial with Addition of BayCare Health System in Florida - ACCESS Newswire

Mar 17, 2025